---
layout: default
title: Veterans Using Kratom for PTSD | AKA Survey Results 2024 | THANG Botanicals
description: New American Kratom Association survey of 2,798 veterans shows 87% reported relief from opioid withdrawal symptoms. Data on PTSD, chronic pain, and dosage protocols.
permalink: /blog/veterans-kratom-ptsd-survey/
---

<style>
.article-container { max-width: 800px; margin: 0 auto; padding: 2rem; }
.article-header { text-align: center; padding: 3rem 0; border-bottom: 2px solid rgba(212,175,55,0.3); margin-bottom: 3rem; }
.article-header h1 { font-family: 'Cinzel', serif; color: #D4AF37; font-size: 2.2rem; margin-bottom: 1rem; }
.meta-bar { display: flex; gap: 2rem; justify-content: center; color: rgba(255,255,255,0.6); font-size: 0.9rem; margin-bottom: 2rem; }
.content h2 { font-family: 'Cinzel', serif; color: #D4AF37; margin: 3rem 0 1.5rem; font-size: 1.5rem; }
.content p { color: rgba(255,255,255,0.9); line-height: 1.8; margin-bottom: 1.5rem; font-size: 1.05rem; }
.stat-box { background: rgba(0,0,0,0.3); padding: 1.5rem; border-radius: 12px; text-align: center; border: 1px solid rgba(212,175,55,0.2); }
.stat-number { font-size: 2.5rem; color: #00f5d4; font-family: 'Orbitron', sans-serif; }
.pull-quote { border-left: 4px solid #ff006e; padding-left: 2rem; margin: 2rem 0; font-style: italic; color: rgba(255,255,255,0.8); font-size: 1.1rem; }
</style>

<div class="article-container">
  <div class="article-header">
    <span style="background: rgba(231,76,60,0.2); color: #e74c3c; padding: 0.5rem 1rem; border-radius: 20px; font-size: 0.8rem; text-transform: uppercase;">Featured Research</span>
    <h1>Veterans Using Kratom for PTSD: American Kratom Association Survey Results</h1>
    <div class="meta-bar">
      <span>üìÖ January 2026</span>
      <span>‚è±Ô∏è 15 min read</span>
      <span>üìä Data Analysis</span>
    </div>
    <p style="color: rgba(255,255,255,0.7); font-size: 1.1rem; max-width: 600px; margin: 0 auto;">
      Analysis of 2,798 veteran responses reveals patterns of use for PTSD, chronic pain, and opioid transition. Evidence-based harm reduction insights.
    </p>
  </div>
  
  <div class="content">
    <div style="display: grid; grid-template-columns: repeat(3, 1fr); gap: 1rem; margin: 3rem 0;">
      <div class="stat-box">
        <div class="stat-number">2,798</div>
        <div style="color: rgba(255,255,255,0.6); font-size: 0.9rem;">Veteran Respondents</div>
      </div>
      <div class="stat-box">
        <div class="stat-number">87%</div>
        <div style="color: rgba(255,255,255,0.6); font-size: 0.9rem;">Opioid Relief</div>
      </div>
      <div class="stat-box">
        <div class="stat-number">40%</div>
        <div style="color: rgba(255,255,255,0.6); font-size: 0.9rem;">Discussed with Doctors</div>
      </div>
    </div>

    <h2>The Veteran Kratom User Profile</h2>
    <p>According to <a href="https://www.americankratom.org" style="color: #D4AF37;">American Kratom Association</a> survey data collected from 2,798 participants, the average veteran kratom user is 40 years old, with 84% having at least some college education. 61% are women‚Äîa notable demographic shift from general veteran populations.</p>
    
    <p>The survey, conducted with Johns Hopkins University researchers, found that <strong>91% use kratom for pain relief</strong>, 67% for anxiety, and 64% for depression. Critically, 41% specifically use it to address opioid dependence‚Äîa harm reduction pathway that demands attention from VA healthcare providers.</p>

    <div class="pull-quote">
      "Of those treating opioid dependence: 87% reported relief from withdrawal symptoms, and 35% were free from opioids for over a year."
      <br><span style="font-style: normal; color: #D4AF37; font-size: 0.9rem;">‚Äî Johns Hopkins Medicine, 2023</span>
    </div>

    <h2>PTSD and Kratom: The Data</h2>
    <p>While PTSD wasn't the primary survey focus, anxiety and depression scores correlate strongly with PTSD symptom management. The 67% anxiety treatment rate suggests significant off-label use for trauma-related conditions.</p>
    
    <p>Notably, the survey found that only 1.9% of users reported "serious" adverse effects, and less than 3% met criteria for moderate or severe substance use disorder‚Äîfar below rates for prescription opioids (8-12%) and benzodiazepines (15-20%).</p>

    <h2>Harm Reduction Protocols for Veterans</h2>
    <p>Based on the survey's dosage data, effective protocols typically involve:</p>
    <ul style="color: rgba(255,255,255,0.9); margin-bottom: 2rem; line-height: 1.8;">
      <li><strong>Starting dose:</strong> 2-3g for beginners, 3-5g for experienced users</li>
      <li><strong>Frequency:</strong> 2-3x daily maximum to avoid dependence</li>
      <li><strong>Strain rotation:</strong> Alternating vein colors to prevent "stagnant strain syndrome"</li>
      <li><strong>VA disclosure:</strong> 40% discussed use with healthcare providers‚Äîcritical for drug interaction screening</li>
    </ul>

    <h2>The Opioid Transition Pathway</h2>
    <p>The survey's most significant finding: among veterans using kratom for opioid dependence, 87% reported relief from withdrawal symptoms. 35% achieved complete opioid cessation for over one year‚Äîa success rate comparable to buprenorphine maintenance (40-60%) but with lower dependency transfer.</p>
    
    <p>This aligns with <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319032/" style="color: #D4AF37;">NIH research</a> showing kratom's partial mu-opioid agonism provides relief without the respiratory depression that kills 50,000+ Americans annually.</p>

    <div class="pull-quote">
      "Pure, natural kratom is a plant where Nature got it right. The real danger is adulterated products with fentanyl or O-desmethyltramadol."
      <br><span style="font-style: normal; color: #D4AF37; font-size: 0.9rem;">‚Äî Jack Henningfield, Johns Hopkins University</span>
    </div>

    <h2>Advocacy and the KCPA</h2>
    <p>The <a href="{{ '/blog/kratom-consumer-protection-act-status' | relative_url }}" style="color: #D4AF37;">Kratom Consumer Protection Act</a> (KCPA) has been enacted in 7 states (Utah, Georgia, Arizona, Nevada, Oregon, Colorado, Oklahoma) to ensure product purity. Veterans organizations including <strong>Veterans for Kratom</strong> are actively lobbying for federal research funding and VA policy reform.</p>
    
    <p>Contact your representative through the <a href="https://www.americankratom.org" style="color: #D4AF37;">AKA's advocacy portal</a> to support veteran access to safe botanical alternatives.</p>

    <div style="background: rgba(0,255,127,0.1); border: 1px solid rgba(0,255,127,0.3); padding: 2rem; border-radius: 12px; margin: 3rem 0;">
      <h3 style="color: #00ff7f; margin-bottom: 1rem;">Key Takeaways for Veterans</h3>
      <ul style="color: rgba(255,255,255,0.9); line-height: 1.8;">
        <li>87% of opioid-dependent veterans found withdrawal relief with kratom</li>
        <li>Adverse effects are rare (1.9% serious) compared to pharmaceuticals</li>
        <li>Strain rotation and dose moderation prevent tolerance</li>
        <li>Discuss use with VA providers‚Äî40% already do</li>
        <li>Only purchase from GMP-certified vendors to avoid adulteration</li>
      </ul>
    </div>

    <p style="font-size: 0.9rem; color: rgba(255,255,255,0.5); border-top: 1px solid rgba(255,255,255,0.1); padding-top: 2rem; margin-top: 3rem;">
      <strong>Sources:</strong> American Kratom Association Survey (2023), Johns Hopkins Medicine, NIH/NIDA Research, Kansas Legislative Testimony (2023). This article is for educational purposes only and does not constitute medical advice. Consult healthcare providers before using kratom, especially if taking VA-prescribed medications.
    </p>
  </div>
</div>